38 results
8-K
EX-2.1
ODYY
Odyssey Health, Inc.
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
with any Governmental Authority, including but not limited to any filings under the Employee Plans Compliance Resolution System or the Department … or inquiry by the Internal Revenue Service or United States Department of Labor. Neither the Company nor any ERISA Affiliate has any Liability under Section
8-K
EX-10.3
sp2 vkb430roha
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
9v8krqzzomqqw6
23 Nov 22
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
7mkl0o20dr
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-10.2
glm0j37tsv
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
DEF 14A
pz7 gc6ui7u3cad1n
6 Aug 21
Definitive proxy
4:02pm
PRER14A
8tsc88 9bz3ksxwx
28 May 21
Preliminary revised proxy
5:09pm